1,188 filings
Page 3 of 60
8-K
xw7mbncxm5h9xaj
2 Jun 20
Entry into a Material Definitive Agreement
7:35am
8-K
6mtdk7dm
8 May 20
VIVUS Q1 2020 Earnings Conference Call
4:45pm
8-K
fphfutzp9ne53
6 May 20
VIVUS Reports First Quarter 2020 Financial Results
4:10pm
8-K
irn903sm9 qd
1 May 20
VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt
8:30am
CT ORDER
yeibvfwqhq8m 4dpr93f
24 Apr 20
Confidential treatment order
2:36pm
SC 13G
7r2xx n08dfw1s2n
13 Apr 20
VIVUS / ARMISTICE CAPITAL ownership change
4:35pm
SC 13G
oeohkvpqdah bncysozy
10 Apr 20
VIVUS / INTRACOASTAL CAPITAL ownership change
4:27pm
8-K
j0mfv6w8lnu2oacu
3 Apr 20
VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
3:05pm
8-K
virpg3ujy9 yq
2 Apr 20
Entry into a Material Definitive Agreement
5:28pm
424B5
8xtp38hc006yc378ex2
2 Apr 20
Prospectus supplement for primary offering
2:01pm
8-K
wz7xc1wuyf
1 Apr 20
VIVUS Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:00pm
SC 13G
r690sd4namo0am1zwt
1 Apr 20
VIVUS / SABBY MANAGEMENT ownership change
9:24am
8-K
nnwwpz6w
31 Mar 20
Other Events
7:35am
CT ORDER
50j2scopqav3 y0
12 Mar 20
Confidential treatment order
1:06pm
8-K
isjrmfp0 wcz4r6
6 Mar 20
VIVUS Q4 2019 Earnings Conference Call
4:05pm
424B5
hmx4c5e3ke6o28rz
6 Mar 20
Prospectus supplement for primary offering
12:00am
8-K
p1z4hh7 nkkgpv
6 Mar 20
Entry into a Material Definitive Agreement
12:00am
8-K
ijaekcd x65
3 Mar 20
VIVUS Reports Fourth Quarter and Full Year 2019 Financial Results
4:10pm